Dyna Scientific Technology Files IPO Application with HKEX, Eyes Capital Market Debut

Dyna Scientific Technology Officially Files with HKEX

According to the latest disclosure documents from the HKEX, Beijing Dyna Scientific Technology Co., Ltd. (hereinafter referred to as "Dyna Scientific Technology") has officially submitted its listing application to the Hong Kong Stock Exchange, with CMB International and Sinolink Securities (Hong Kong) serving as joint sponsors. This marks a critical step in the company's push toward the Hong Kong capital market.

Company Background: Deep Expertise in Laboratory Technology

Headquartered in Beijing, Dyna Scientific Technology is a company specializing in laboratory scientific instruments and related technical services. The company has long been deeply engaged in the laboratory technology sector, committed to providing professional integrated laboratory solutions for research institutions, universities, and corporate clients. In recent years, as China has continuously increased investment in technological innovation and fundamental research, the laboratory equipment and services industry has entered a period of rapid growth, and Dyna Scientific Technology has been steadily expanding within this track.

Sponsor Lineup Sends Positive Signal

This IPO features CMB International and Sinolink Securities (Hong Kong) as joint sponsors. CMB International, the international investment banking platform under China Merchants Bank, boasts extensive sponsorship and underwriting experience in the Hong Kong stock market. Sinolink Securities (Hong Kong) has also been frequently active in the Hong Kong IPO market in recent years. The collaboration of these two major sponsoring institutions demonstrates the capital market's confidence in Dyna Scientific Technology's growth prospects.

Industry Context: Laboratory Services Market Continues to Heat Up

From a broader industry perspective, China's laboratory technology services market is in a phase of rapid development. Multiple favorable factors are driving the industry's growth:

• Policy Support: China's 14th Five-Year Plan explicitly calls for strengthening fundamental research and original innovation, with annual increases in research funding directly boosting demand for laboratory equipment and services.
• Industrial Upgrading: The rapid development of emerging industries such as biopharmaceuticals, new materials, and new energy has generated significant demand for laboratory construction and upgrades.
• Domestic Substitution Trend: In the laboratory instrument and equipment sector, domestic brands are gradually replacing imported products, creating vast market opportunities for local enterprises.

Outlook

This filing with the HKEX holds significant importance for Dyna Scientific Technology. If the listing is successful, the company will leverage the capital market to further expand its business scale, enhance its R&D capabilities, and is expected to consolidate its competitive edge in the laboratory technology services niche.

Notably, the Hong Kong stock market has maintained a high degree of inclusiveness and attention toward technology companies in recent years, with multiple mainland Chinese tech firms having successfully listed on the HKEX. Whether Dyna Scientific Technology can smoothly pass the listing hearing and complete its IPO, as well as its subsequent pricing and market performance, remains to be seen.

Currently, specific financial data and intended use of proceeds detailed in the listing application are pending further disclosure by the HKEX. We will continue to monitor the latest developments of this event.